Φορτώνει......
Levodopa-carbidopa enteral suspension in advanced Parkinson’s disease: clinical evidence and experience
The duration of action of oral levodopa becomes shorter as Parkinson’s disease (PD) progresses. Patients with advanced PD may develop potentially disabling motor fluctuations and abnormal involuntary movement (dyskinesia), which cannot be managed with optimized oral or transdermal PD medications. Th...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Ther Adv Neurol Disord |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5349373/ https://ncbi.nlm.nih.gov/pubmed/28344656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616681280 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|